跳到正文
原文
Medical Xpress·· 22 天前精选AI 评分68

Cell 研究显示穿孔素可独立诱导肿瘤细胞铁死亡

Immune system protein is a cancer killer on its own, new study shows

AI 导读

密歇根大学 Rogel 癌症中心团队在 Cell 发表研究,发现穿孔素不依赖颗粒酶也能诱导肿瘤细胞铁死亡。体外与小鼠实验显示,穿孔素可干扰肿瘤细胞的铁摄取,使铁在线粒体内蓄积并氧化脂质;穿孔素表达较高的患者生存更好、对免疫检查点阻断治疗的反应也更佳。研究者提醒不宜据此给所有患者补铁,部分肿瘤可能因富铁饮食加速进展。

推荐理由

研究用细胞、小鼠与患者数据三条线索,提出穿孔素可独立经铁死亡途径杀伤肿瘤细胞,为免疫治疗机制提供新解释。

正文 · 原文
Immune system protein is a cancer killer on its own, new study shows
Perforin increases endosomal-mitochondrial contact sites in tumor cells. Left has no perforin; right is with perforin. Credit: University of Michigan Rogel Cancer Center

For decades, scientists have known that a protein made by T cells and natural killer (NK) cells in the immune system, called perforin, can kill tumor cells by punching a hole in the cell wall and injecting proteases called granzymes, which kill the cell. Now, new work led by researchers at the University of Michigan Health Rogel Cancer Center found that tumor cells could be killed even when major granzymes were missing.

"If T cells and NK cells are the soldiers of the immune system, perforin is the weapon, and granzymes are the ammunition," said co-senior study author Weiping Zou, Charles B. de Nancrede professor of pathology, immunology, biology and surgery at U-M. "At least, that's what the classic understanding was."

Their new study, published in Cell, reveals that perforin is a cancer killer on its own, no major granzymes needed. They also found that a loss of perforin causes a catastrophic failure of antitumor immunity. The discoveries will likely have implications for understanding how cancers are killed by immune cells and could have ripple effects throughout the field of immunology.

"Our findings show, for the first time, that perforin can independently induce ferroptosis in tumor cells," said co-senior author Ilona Kryczek, a researcher at U-M. "This work changes our understanding of one of the longest-held mechanisms of T cell– and NK cell–mediated tumor clearance."

Zou and Kryczek collaborated closely with co-senior author Judy Lieberman of Harvard Medical School, one of the international pioneers of cytotoxic lymphocyte research.

An iron-dependent route to cell death

Cells can face different forms of death. There's apoptosis, which is what granzymes do. Pyroptosis is a form of cell death often caused by bacterial infection. And there's ferroptosis, which is an iron-dependent form of cell death driven by the accumulation of lipid peroxides in cellular and organelle membranes. Ferroptosis is a relatively new concept, formally introduced over a decade ago, so scientists know less about it than other, more well-established forms of cell death.

"It's a very hot area that needs a lot of research," Zou said. In 2019, his group was the first to report the immune system's role in ferroptosis in tumors, highlighting its potential as a target pathway for immune checkpoint therapy. But questions remained: Could perforin on its own really kill cancer cells? And if so, how?

Evidence from cells, mice and patients

To find out, Zou and collaborators took a three-pronged research approach, pairing in vitro experiments of genetic and biochemical manipulations with in vivo mouse studies and human cancer patient data.

The in vitro experiments revealed that perforin without granzymes is still deadly to cancer cells, with ferroptosis as the mechanism. Mice with an iron-rich diet had slower tumor progression that was related to their perforin expression. And cancer patients with higher perforin expression saw improved survival and better responses to immune checkpoint blockade treatments.

With those three lines of evidence, the answer to Zou's first question was clear.

"We wanted to know if perforin, by itself, can do the job," he said. "The answer is yes."

How perforin disrupts iron balance

"It is a new way of thinking about how immune cells kill tumors," said Hannah Bell, the study's first author and a recent postdoc in Zou's lab who is now an assistant professor in molecular and integrative physiology at U-M.

Perforin is capable of not only punching a hole in the target cell membrane, but also of interfering with the target cell's iron uptake so that it accumulates problematically inside the cell, including inside the mitochondria. There, the excess iron rapidly oxidizes lipids. The cell's whole system goes haywire, and the tumor cell dies.

Caution over iron-rich diets

The takeaway is not to give all cancer patients an iron-rich diet. "We need to be very cautious here," Zou said. "That's because some cancer types enjoy an iron-rich diet. For those tumors, and we don't totally know which ones yet, an iron-rich diet may accelerate progression."

It's mostly too soon to say what the clinical applications of the finding will be, but previous work found that immune checkpoint blockade can enhance T cell–mediated ferroptosis, so that's likely an avenue of future research. "If we can understand what makes a tumor cell susceptible to perforin, we may be able to increase the effectiveness of immunotherapy," Zou said.

The team's future research will delve deeper into the mechanism of cell death, test whether multiple cell death pathways could be working together and make inroads to clinical applications.

"At the end of the day, the whole goal of different forms of cancer therapies—immunotherapy, chemotherapy, targeted therapy—is to kill tumor cells," Zou said. "Improving our understanding of cell death, like we do in this study, is so fundamental and so important. That's why we're going to continue to push on this."

Publication details

Hannah N. Bell et al., Perforin triggers iron-induced mitochondrial damage to drive ferroptosis and anti-tumor immunity, Cell (2026). DOI: 10.1016/j.cell.2026.09.062

Journal information: Cell

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Immune system protein is a cancer killer on its own, new study shows (2026, October 29) retrieved 29 October 2026 from https://medicalxpress.com/news/2026-10-immune-protein-cancer-killer.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com